Human Genome Epidemiology Literature Finder
Records 1 - 12 (of 12 Records) |
Query Trace: Arthritis and ITPA[original query] |
---|
Relationship between genetic variants in the adenosine pathway and outcome of methotrexate treatment in patients with recent-onset rheumatoid arthritis. Arthritis and rheumatism 2006 Sep 54 (9): 2830-9. Wessels Judith A M, Kooloos Wouter M, De Jonge Robert, De Vries-Bouwstra Jeska K, Allaart Cornelia F, Linssen Annelies, Collee Gerard, De Sonnaville Peter, Lindemans Jan, Huizinga Tom W J, Guchelaar Henk-J |
A clinical pharmacogenetic model to predict the efficacy of methotrexate monotherapy in recent-onset rheumatoid arthritis. Arthritis and rheumatism 2007 Jun 56 (6): 1765-75. Wessels Judith A M, van der Kooij Sjoerd M, le Cessie Saskia, Kievit Wietske, Barerra Pilar, Allaart Cornelia F, Huizinga Tom W J, Guchelaar Henk-Jan, |
Investigation of candidate polymorphisms and disease activity in rheumatoid arthritis patients on methotrexate. Rheumatology (Oxford, England) 2009 Jun 48 (6): 613-7. Lee Yvonne C, Cui Jing, Costenbader Karen H, Shadick Nancy A, Weinblatt Michael E, Karlson Elizabeth |
Functional polymorphisms and methotrexate treatment outcome in recent-onset rheumatoid arthritis. Pharmacogenomics 2010 Feb 11 (2): 163-75. Kooloos Wouter M, Wessels Judith Am, van der Straaten Tahar, Allaart Cornelia F, Huizinga Tom Wj, Guchelaar Henk-J |
Association of the 5-aminoimidazole-4-carboxamide ribonucleotide transformylase gene with response to methotrexate in juvenile idiopathic arthritis. Annals of the rheumatic diseases 2011 Aug 70 (8): 1395-400. Hinks Anne, Moncrieffe Halima, Martin Paul, Ursu Simona, Lal Sham, Kassoumeri Laura, Weiler Tracey, Glass David N, Thompson Susan D, Wedderburn Lucy R, Thomson Wen |
Clinical pharmacogenetic model to predict response of MTX monotherapy in patients with established rheumatoid arthritis after DMARD failure. Pharmacogenomics 2012 Jul 13 (9): 9. Fransen J, Kooloos WM, Wessels JA, Huizinga TW, Guchelaar HJ, van Riel PL, Barrera P |
Genetic polymorphisms in key methotrexate pathway genes are associated with response to treatment in rheumatoid arthritis patients. The pharmacogenomics journal 2012 Mar . Owen SA, Hider SL, Martin P, Bruce IN, Barton A, Thomson W |
5-Aminoimidazole-4-carboxamide ribonucleotide-transformylase and inosine-triphosphate-pyrophosphatase genes variants predict remission rate during methotrexate therapy in patients with juvenile idiopathic arthritis. Rheumatology international 2015 Apr 35 (4): 619-27. Pastore Serena, Stocco Gabriele, Moressa Valentina, Zandonà Luigi, Favretto Diego, Malusà Noelia, Decorti Giuliana, Lepore Loredana, Ventura Alessand |
Effect of genetic polymorphisms of azathioprine-metabolizing enzymes on response to rheumatoid arthritis treatment. Die Pharmazie 2017 Jan 72 (1): 22-28. Tsuchiya A, Aomori T, Sakamoto M, Takeuchi A, Suzuki S, Jibiki A, Otsuka N, Ishioka E, Kaneko Y, Takeuchi T, Nakamura |
Polymorphism of genes involved in methotrexate pathway: Predictors of response to methotrexate therapy in Indian rheumatoid arthritis patients. International journal of rheumatic diseases 2021 Mar . Singh Ankita, Gangadharan Harikrishnan, Gupta Vikas, Patro Pradeepta S, Misra Ramnath, Aggarwal Ami |
Is Pharmacogenetic Panel Testing Applicable to Low-Dose Methotrexate in Rheumatoid Arthritis? - A Case Report. Pharmacogenomics and personalized medicine 2022 5 15 465-475. Jeiziner Chiara, Allemann Samuel S, Hersberger Kurt E, Meyer Zu Schwabedissen Henriette |
Pharmacogenetic Sex-Specific Effects of Methotrexate Response in Patients with Rheumatoid Arthritis. Pharmaceutics 2023 6 15 (6): . Francisco C Ceballos, Eugenio Chamizo-Carmona, Carmen Mata-Martín, Carmen Carrasco-Cubero, Juan J Aznar-Sánchez, Raúl Veroz-González, Sara Rojas-Herrera, Pedro Dorado, Adrián LLere |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: